Health Care & Life Sciences » Biotechnology | Epigenomics AG

Epigenomics AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
7,957.00
7,495.00
8,563.00
12,284.00
13,731.00
17,140
Total Accounts Receivable
467.00
472.00
411.00
2,300.00
2,061.00
371
Inventories
277.00
793.00
1,080.00
257.00
305.00
364
Other Current Assets
175.00
170.00
381.00
324.00
762.00
399
Total Current Assets
8,876.00
8,930.00
10,435.00
15,165.00
16,859.00
18,274
Net Property, Plant & Equipment
247.00
1,013.00
684.00
713.00
720.00
701
Intangible Assets
1,920.00
1,291.00
792.00
755.00
668.00
474
Other Assets
38.00
38.00
341.00
38.00
-
-
Total Assets
11,081.00
11,320.00
12,598.00
18,222.00
19,773.00
21,827
ST Debt & Current Portion LT Debt
1,932.00
1,926.00
1,070.00
-
6,536.00
Accounts Payable
1,030.00
897.00
1,923.00
1,089.00
952.00
Income Tax Payable
84.00
159.00
76.00
114.00
91.00
Other Current Liabilities
1,034.00
823.00
2,214.00
2,506.00
1,574.00
Total Current Liabilities
4,080.00
3,805.00
5,283.00
3,709.00
9,153.00
Provision for Risks & Charges
542.00
1,407.00
217.00
89.00
43.00
Deferred Taxes
-
48.00
346.00
1,551.00
1,526.00
Total Liabilities
4,622.00
5,212.00
5,500.00
3,798.00
9,196.00
Common Equity (Total)
6,459.00
6,108.00
7,098.00
14,424.00
10,577.00
Total Shareholders' Equity
6,459.00
6,108.00
7,098.00
14,424.00
10,577.00
Total Equity
6,459.00
6,108.00
7,098.00
14,424.00
10,577.00
Liabilities & Shareholders' Equity
11,081.00
11,320.00
12,598.00
18,222.00
19,773.00

About Epigenomics

View Profile
Address
Geneststraße 5
Berlin Berlin 10829
Germany
Employees -
Website http://www.epigenomics.de
Updated 07/08/2019
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, and Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA. The comapny was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo Gut on April 30, 1997 and is headquartered in Berlin, Germany.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.